Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00015938 | S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer | completed | Phase 2 | 95 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00024154 | Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 132 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00098397 | FR901228 in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00025584 | PS-341 in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 35 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00045188 | Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 35 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00967031 | Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain Metastases | completed | Phase 2 | 45 | UNICANCEROTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00017394 | Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer | completed | Phase 2 | 56 | National Cancer Institute (NCI)NIH | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00059943 | Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00540358 | A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer | completed | Phase 2 | 123 | SanofiINDUSTRY | 1 | Dec 28, 2012 | clinicaltrials |
| NCT00001832 | Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma | completed | Phase 2 | 170 | National Cancer Institute (NCI)NIH | 1 | Dec 21, 2012 | clinicaltrials |
| NCT00981864 | Concurrent Boost Radiotherapy | completed | Phase 2 | 17 | University Health Network, TorontoOTHER | 1 | Dec 21, 2012 | clinicaltrials |
| NCT00416403 | Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer | completed | Phase 2 | 35 | University of California, San FranciscoOTHER | 1 | Dec 13, 2012 | clinicaltrials |
| NCT00003352 | Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer | completed | Phase 2 | 89 | NSABP Foundation IncNETWORK | 3 | Dec 11, 2012 | clinicaltrials |
| NCT00429104 | Herceptin and GM-CSF for Metastatic Breast Cancer | completed | Phase 2 | 18 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00586326 | MammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-Situ(DCIS) | completed | Phase 2 | 133 | Hologic, Inc.INDUSTRY | 1 | Nov 6, 2012 | clinicaltrials |
| NCT00212095 | Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer | completed | Phase 2 | 30 | National University Hospital, SingaporeOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00695994 | The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian Patients | completed | Phase 2 | 300 | National University Hospital, SingaporeOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00005798 | Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer(CTC) | completed | Phase 2 | 209 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Oct 26, 2012 | clinicaltrials |
| NCT00037609 | Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients | completed | Phase 1 / Phase 2 | 35 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 24, 2012 | clinicaltrials |
| NCT00078845 | Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors | completed | Phase 2 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 17, 2012 | clinicaltrials |
| NCT00148070 | Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer | completed | Phase 2 | 45 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 5, 2012 | clinicaltrials |
| NCT00007904 | Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes | completed | Phase 2 | 16 | Case Comprehensive Cancer CenterOTHER | 1 | Oct 2, 2012 | clinicaltrials |
| NCT00636467 | Axillary Sentinel Lymph Node Detection in Breast Cancers > 2 cm(GAS2PLUS) | completed | Phase 2 | 249 | Centre Leon BerardOTHER | 1 | Sep 26, 2012 | clinicaltrials |
| NCT00005800 | Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer | completed | Phase 2 | 45 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT01044485 | Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer(LapDoc) | completed | Phase 1 / Phase 2 | 17 | Centre Georges Francois LeclercOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00028977 | Herbal Therapy in Treating Women With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 21 | University of California, San FranciscoOTHER | 1 | Sep 17, 2012 | clinicaltrials |
| NCT00194727 | Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer | completed | Phase 2 | 40 | University of WashingtonOTHER | 1 | Sep 13, 2012 | clinicaltrials |
| NCT00194753 | Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12 | completed | Phase 2 | 80 | University of WashingtonOTHER | 1 | Sep 13, 2012 | clinicaltrials |
| NCT00633750 | Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery | completed | Phase 2 | 50 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Sep 5, 2012 | clinicaltrials |
| NCT01190982 | Efficacy and Safety Study of LEP-ETU to Treat Metastatic Breast Cancer | completed | Phase 2 | 70 | INSYS Therapeutics IncINDUSTRY | 1 | Aug 24, 2012 | clinicaltrials |
| NCT00364611 | Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer | completed | Phase 2 | 73 | SanofiINDUSTRY | 1 | Aug 23, 2012 | clinicaltrials |
| NCT00988936 | Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug(K5-101) | completed | Phase 2 | 35 | Siemens Molecular ImagingINDUSTRY | 1 | Aug 22, 2012 | clinicaltrials |
| NCT00232479 | Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast Cancer | completed | Phase 2 | 48 | University of MiamiOTHER | 1 | Aug 21, 2012 | clinicaltrials |
| NCT00259090 | Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer | completed | Phase 2 | 120 | AstraZenecaINDUSTRY | 1 | Aug 16, 2012 | clinicaltrials |
| NCT01003951 | Acupuncture for the Treatment of Chronic Lymphedema | completed | Phase 2 | 37 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 16, 2012 | clinicaltrials |
| NCT00943410 | Trastuzumab and External Beam Radiation Therapy in Treating Women With Stage III or Stage IV Breast Cancer | completed | Phase 2 | 19 | UNC Lineberger Comprehensive Cancer CenterOTHER | 0 | Aug 15, 2012 | clinicaltrials |
| NCT00006104 | Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer | completed | Phase 2 | 46 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 14, 2012 | clinicaltrials |
| NCT00429572 | Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer | completed | Phase 2 | 19 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT01149798 | A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer | completed | Phase 2 | 73 | Fudan UniversityOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00299286 | Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast Cancer(MAPLE) | completed | Phase 2 | 121 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 6, 2012 | clinicaltrials |
| NCT00002837 | High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer | completed | Phase 1 / Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00003099 | Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer | completed | Phase 2 | 52 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00005980 | Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 116 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 18, 2012 | clinicaltrials |
| NCT00028873 | R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy | completed | Phase 2 | 35 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Jul 18, 2012 | clinicaltrials |
| NCT00066339 | Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy | completed | Phase 2 | 44 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 18, 2012 | clinicaltrials |
| NCT00401427 | HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer | completed | Phase 2 | 50 | National Cancer Institute, NaplesOTHER | 0 | Jul 13, 2012 | clinicaltrials |
| NCT00788333 | Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer | completed | Phase 1 / Phase 2 | 40 | Bristol-Myers SquibbINDUSTRY | 5 | Jul 13, 2012 | clinicaltrials |
| NCT00246571 | Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer | completed | Phase 2 | 217 | PfizerINDUSTRY | 12 | Jul 12, 2012 | clinicaltrials |
| NCT00529984 | A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies(CEA(6D)VRP) | completed | Phase 1 / Phase 2 | 28 | AlphaVax, Inc.INDUSTRY | 1 | Jul 12, 2012 | clinicaltrials |
Data updated 24 days agoSource updated Jan 24, 2013source: clinicaltrials